8 completed. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 2 | Completed 2 |
Follow Pediatric Obesity: new trials by email Literature Review of Pediatric Obesity trials Research Report on Pediatric Obesity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study) Essential Amino Acid Supplement by Amino Co, Placebo - Hepatic Steatosis, NAFLD | Phase 3 | Completed | University of Colorado, Denver | 31 | 2024-06-18 | 2026-08-31 |
| Eat My ABCs Project Eat My ABCs - Nutrition, Healthy, Obesity, Childhood | Phase 2 / Phase 3 | Completed | Michigan State University | 202 | 2023-01-01 | 2024-06-07 |
| Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity Setmelanotide - Bardet-Biedl Syndrome, POMC Deficiency Obesity | Phase 3 | Completed | Rhythm Pharmaceuticals, Inc. | 12 | 2022-03-08 | 2024-11-27 |
| Treating PCOS With Semaglutide vs Active Lifestyle Intervention Semaglutide 3mg and 7mg [Rybelsus], Weight loss diet - PCOS, Adolescent Obesity | Phase 2 / Phase 3 | Completed | University of Colorado, Denver | 60 | 2019-05-03 | 2025-11-25 |
| The Optimising Family Engagement in HENRY (OFTEN) Study Optimisation + HENRY, HENRY as standard - Childhood Obesity | Phase 3 | Completed | University of Leeds | 126 | 2015-10-01 | 2022-03-25 |
| Obalon in Children With Severe Obesity Swallowable Obalon® Gastric Balloon - Severe Pediatric Obesity (BMI > 97° pc -According to Centers for Disease Control and Prevention BMI Charts-), Altered Liver Function Tests | Phase 3 | Completed | Bambino Gesù Hospital and Research Institute | 10 | 2014-01-01 | 2015-07-22 |
| Effect of Mindful Eating on Body Mass Index in Obese Adolescents Mindful Eating, Standard dietary counselling - Adolescent Obesity | Phase 3 | Completed | Mayo Clinic | 21 | 2012-12-01 | 2014-01-22 |
| Propofol in Obese Children Propofol - Pharmacodynamics, Obesity | Phase 3 | Completed | Baylor College of Medicine | 80 | 2008-04-01 | 2020-12-21 |
Obesity (3) · Non-alcoholic Fatty Liver Disease (2) · Bardet-Biedl Syndrome (1) · Fatty Liver (1) · Insulin Resistance (1) · Obesity, Morbid (1) · Proopiomelanocortin Deficiency (1)
Body Weight (8) · Nutrition Disorders (8) · Nutritional and Metabolic Diseases (8) · Overnutrition (8) · Overweight (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Obesity (5) · Digestive System Diseases (2) · Liver Diseases (2) · Abnormalities, Multiple (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Ciliopathies (1) · Congenital Abnormalities (1)
Diet, Reducing (1) · Propofol (1) · semaglutide (1) · setmelanotide (1)
University of Colorado, Denver (2) · Bambino Gesù Hospital and Research Institute (1) · Baylor College of Medicine (1) · Mayo Clinic (1) · Michigan State University (1) · Rhythm Pharmaceuticals, Inc. (1) · University of Leeds (1)
United States (6) · United Kingdom (2) · Australia (1) · Italy (1) · Spain (1)
David Meeker, MD (1) · Melanie Cree, MD, PhD (1) · Melanie Cree-Green, MD, PhD (1) · Olutoyin A Olutoye, MD (1) · Seema Kumar, MD (1)
PMID 28115006, PMID 34740373, PMID 39549719, PMID 41475815, PMID 41978152, PMID 42014131
R01DK120612 (1), R44DK135312 (1)